Shilpa Medicare Ltd. (SHILPAMED) Share Price Hits Fresh 52-Week High
- August 4, 2026
- Posted by: Harsh Piplani
- Category: News
Shilpa Medicare Ltd. Share Price reached a fresh 52-week high of Rs 655.6, marking a 3.55% increase today. The market cap stands at Rs 11,960.81 crore.
Shilpa Medicare Ltd. Share Price has surged to a fresh 52-week high of Rs 655.6, reflecting a 3.55% increase from the previous close of Rs 623.3. The stock opened at Rs 630.4 and reached a low of Rs 622.35 during the day. With a market capitalisation of Rs 11,960.81 crore, Shilpa Medicare Ltd. is attracting significant investor attention. This milestone highlights the company’s strong market presence and investor confidence in its growth prospects.
Shilpa Medicare Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 645.4 |
| Previous Close | Rs 623.3 |
| Today's Change | +Rs 22.1 (+3.55%) |
| Day Open | Rs 630.4 |
| Fresh 52-Week High | Rs 655.6 |
| Day Low | Rs 622.35 |
| Current Volume | 41,462 |
| Turnover | Rs 2.68 crore |
| Market Capitalisation | Rs 11,960.81 crore |
Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 645.4. versus the previous close of Rs 623.3, a rise of 3.55%. The stock opened at Rs 630.4, reached Rs 655.6, touched Rs 622.35. Reported volume was 41,462.
Today, Shilpa Medicare Ltd. Share Price opened at Rs 630.4 and quickly climbed to a fresh 52-week high of Rs 655.6. The stock closed at Rs 645.4, up by Rs 22.1 or 3.55% from the previous close of Rs 623.3. The day’s low was Rs 622.35, and the turnover reached Rs 2.68 crore with a volume of 41,462 shares. This price action indicates strong market interest and momentum.
Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 11,960.81 crore |
| P/E Ratio | 39.39x |
| P/B Ratio | 7.98x |
| ROE | 28.21% |
| ROCE | 26.35% |
Shilpa Medicare Ltd. was valued at a P/E ratio of 39.39x, a P/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.39x |
| Benchmark Median P/E | 20.89x |
| Benchmark Average P/E | 73.74x |
| Benchmark P/E Range | 0x to 3,364.06x |
| Company P/B Ratio | 7.98x |
| Benchmark Median P/B | 1.9x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 11,960.81 crore |
| Benchmark Median Market Cap | Rs 139.24 crore |
Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare.
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.39 | 7.98 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 62.88 | 9.95 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,421.1 | 34.54 | 6.99 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,416.82 | 171.93 | 3.18 | 13.9 | 12.97 |
| Hester Biosciences Ltd. | HESTERBIO | 2,111.45 | 15.25 | 4.57 | 16.17 | 14.12 |
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 11,960.81 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare Ltd.
- Shilpa Medicare Ltd. Share Price reached a fresh 52-week high, indicating strong market momentum.
- The company’s strong ROE and ROCE suggest efficient use of capital and equity.
- Valuation metrics show competitive positioning within the Healthcare sector.
- Peer comparison highlights strong profitability relative to industry peers.
About Shilpa Medicare Ltd.
Shilpa Medicare Ltd. operates in the Healthcare sector, focusing on the development and manufacture of pharmaceutical products. The company is known for its robust product portfolio and commitment to quality, serving both domestic and international markets. With a strong emphasis on research and development, Shilpa Medicare Ltd. continues to innovate and expand its offerings, positioning itself as a key player in the pharmaceutical industry.
Track Shilpa Medicare Ltd. Share Price on Univest
Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Shilpa Medicare Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Shilpa Medicare Ltd.?
Ans. The current share price of Shilpa Medicare Ltd. is Rs 645.4, reflecting a 3.55% increase from the previous close of Rs 623.3. The stock moved 3.55% during the session. The intraday range extended from Rs 622.35 to Rs 655.6.
What is Shilpa Medicare Ltd.'s market capitalisation?
Ans. Shilpa Medicare Ltd.'s market capitalisation is Rs 11,960.81 crore, indicating its size and market presence within the Healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.39x.
How does Shilpa Medicare Ltd.'s P/E ratio compare to the sector?
Ans. Shilpa Medicare Ltd.'s P/E ratio of 39.39 is above the sector median of 20.89 but below the average of 73.74, showing a competitive valuation. The company trades at a P/E ratio of 39.39x.
What are Shilpa Medicare Ltd.'s ROE and ROCE?
Ans. Shilpa Medicare Ltd. has a return on equity (ROE) of 28.21% and a return on capital employed (ROCE) of 26.35%, indicating strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%.
How does Shilpa Medicare Ltd. compare to its peers?
Ans. Shilpa Medicare Ltd. shows strong profitability with a P/E ratio of 39.39, similar to Kwality Pharmaceuticals Ltd., and higher ROE and ROCE compared to Beta Drugs Ltd. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye.
What is the 52-week high for Shilpa Medicare Ltd.?
Ans. The 52-week high for Shilpa Medicare Ltd. is Rs 655.6, achieved today, indicating strong market momentum. The stock moved 3.55% during the session. The intraday range extended from Rs 622.35 to Rs 655.6.
What is Shilpa Medicare Ltd.'s P/B ratio?
Ans. Shilpa Medicare Ltd. has a P/B ratio of 7.98, which is significantly higher than the sector median of 1.9, indicating a premium valuation. The company trades at a P/E ratio of 39.39x.
How does Shilpa Medicare Ltd.'s ROE compare to the sector?
Ans. Shilpa Medicare Ltd.'s ROE of 28.21% is significantly higher than the sector median of 10.92%, indicating superior profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.
